Digital How technology is redefining pharmacovigilance Big data, artificial intelligence (AI), and machine learning (ML) are driving a technological revolution in healthcare.
Healthcare Transforming healthcare through sustainable and resilient da... In the past two decades, global spending on health has doubled.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.